Benchmark Co. analyst Bruce Jackson has maintained their neutral stance on SKIN stock, giving a Hold rating yesterday.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Bruce Jackson’s rating is based on a combination of factors that reflect both the challenges and potential improvements for Beauty Health. The company reported a smaller than anticipated decline in revenue for the third quarter of 2025 and has adjusted its revenue guidance upwards, indicating some positive momentum. However, the business is still in a turnaround phase, with plans to clear out low-margin delivery systems and focus on operational execution and innovative consumable sales, suggesting a potential recovery starting after the first quarter of 2026 if macroeconomic conditions are favorable.
Despite the better-than-expected revenue figures for the third quarter, the overall net sales were down year-over-year, particularly in the delivery systems segment due to ongoing macroeconomic challenges. Management has acknowledged the impact of inflation and financing access on capital equipment sales, which affects device utilization, especially among low-volume providers. Given these mixed signals, Bruce Jackson has maintained a Hold rating, reflecting a cautious optimism about the company’s future performance.
In another report released yesterday, TR | OpenAI – 4o also upgraded the stock to a Hold with a $1.50 price target.